These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 10895081)
1. Decreasing cyclic GMP exerts similar positive functional effects on cardiac myocytes regardless of initial level. Yan L; Huang MW; Scholz PM; Weiss HR Pharmacology; 2000 Jul; 61(1):51-6. PubMed ID: 10895081 [TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases. Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228 [TBL] [Abstract][Full Text] [Related]
3. Ethanol reduces cardiac myocyte function through activation of the nitric oxide-cyclic GMP pathway. Weiss H; Haim T; Zhang Q; Vaks Y Pharmacology; 2003 Feb; 67(2):59-66. PubMed ID: 12566849 [TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes. Straznicka M; Gong G; Yan L; Scholz PM; Weiss HR J Cardiovasc Pharmacol; 1999 Aug; 34(2):229-36. PubMed ID: 10445674 [TBL] [Abstract][Full Text] [Related]
5. Relationship between decreased function and O2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels. Yan L; Gong GX; Tse J; Scholz PM; Weiss HR Res Exp Med (Berl); 1998 Oct; 198(3):109-21. PubMed ID: 9820898 [TBL] [Abstract][Full Text] [Related]
6. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity. Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451 [TBL] [Abstract][Full Text] [Related]
7. Functional interaction of a beta-adrenergic agonist and cyclic GMP phosphodiesterase inhibitor in control and hypertrophic cardiomyocytes. Zhang S; Rodriguez R; Scholz PM; Weiss HR Pharmacology; 2006; 76(2):53-60. PubMed ID: 16276122 [TBL] [Abstract][Full Text] [Related]
8. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide. Weisbrod RM; Griswold MC; Yaghoubi M; Komalavilas P; Lincoln TM; Cohen RA Br J Pharmacol; 1998 Dec; 125(8):1695-707. PubMed ID: 9886761 [TBL] [Abstract][Full Text] [Related]
9. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation. Gong GX; Weiss HR; Tse J; Scholz PM Eur J Pharmacol; 1998 Mar; 344(2-3):299-305. PubMed ID: 9600666 [TBL] [Abstract][Full Text] [Related]
10. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes. Wegener JW; Closs EI; Förstermann U; Nawrath H Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560 [TBL] [Abstract][Full Text] [Related]
11. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels. Mulè F; D'Angelo S; Serio R Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253 [TBL] [Abstract][Full Text] [Related]
12. Negative effect of nitric oxide on shortening-frequency relationship in cardiac myocytes is diminished after simulated ischemia-reperfusion. Weiss HR; Gandhi A; Scholz PM Basic Res Cardiol; 2003 Sep; 98(5):311-8. PubMed ID: 12955404 [TBL] [Abstract][Full Text] [Related]
13. Cyclic GMP-induced reduction in cardiac myocyte function is partially mediated by activation of the sarcoplasmic reticulum Ca(2+)-ATPase. Zhang Q; Yan L; Weiss HR; Scholz PM Pharmacology; 2002 Feb; 64(2):106-12. PubMed ID: 11803251 [TBL] [Abstract][Full Text] [Related]
14. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Wegener JW; Gath I; Förstermann U; Nawrath H Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305 [TBL] [Abstract][Full Text] [Related]